Ensign Peak Advisors, Inc Axonics, Inc. Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $269,121 - $347,437	5,450 Added 35.39%	20,850 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $416,920 - $536,200	7,000 Added 83.33%	15,400 $962,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $113,022 - $152,334	1,950 Added 30.23%	8,400 $592,000
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $33,242 - $47,697	760 Added 13.36%	6,450 $404,000
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $284,556 - $417,361	5,690 New	5,690 $319,000

10.1M

5.2K

58.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.